Market Place
Sourcing Support
ICON Announces Appointment of Chief Operating Officer
18 Dec 2024 //
BUSINESSWIRE
ICON plc to Present at the Jefferies London Healthcare Conference
13 Nov 2024 //
BUSINESSWIRE
ICON Reports Third Quarter 2024 Results
23 Oct 2024 //
BUSINESSWIRE
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
27 Sep 2024 //
BUSINESSWIRE
ICON Survey Shows Focus On Precision Therapies In Oncology
12 Sep 2024 //
BUSINESSWIRE
ICON plc to Present at the Baird 2024 Global Healthcare Conference
03 Sep 2024 //
BUSINESSWIRE
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
01 Jul 2024 //
BUSINESSWIRE
ICON plc to Present at the Jefferies Global Healthcare Conference
04 Jun 2024 //
BUSINESSWIRE
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
30 May 2024 //
BUSINESSWIRE
ICON Announces CFO Transition
03 Apr 2024 //
BUSINESSWIRE
ICON plc Schedules First Quarter 2024 Earnings Conference Call
25 Mar 2024 //
BUSINESSWIRE
ICON plc to Present at Upcoming Investor Conferences
26 Feb 2024 //
BUSINESSWIRE
ICON Reports Fourth Quarter and Full Year 2023 Results
21 Feb 2024 //
BUSINESSWIRE
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
30 Jan 2024 //
BUSINESSWIRE
ICON Issues Financial Guidance for Full Year 2024
09 Jan 2024 //
BUSINESSWIRE
Biotech companies to increase R&D spend
08 Jan 2024 //
BUSINESSWIRE
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
BUSINESSWIRE
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
07 Dec 2023 //
BUSINESSWIRE
ICON Reports Third Quarter 2023 Results
25 Oct 2023 //
BUSINESSWIRE
Icon, Saphetor partner on trials targeting precision medicine
18 Oct 2023 //
FIERCE BIOTECH
ICON Secures Upgraded Credit Rating from S&P Global Ratings
12 Oct 2023 //
BUSINESSWIRE
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
21 Sep 2023 //
BUSINESSWIRE
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
20 Sep 2023 //
BUSINESSWIRE
ICON Reports Second Quarter 2023 Results
26 Jul 2023 //
BUSINESSWIRE
ICON Shareholders Vote in Favour of All Resolutions at Annual General Meeting
26 Jul 2023 //
BUSINESSWIRE
ICON plc Schedules Second Quarter 2023 Earnings Conference Call
27 Jun 2023 //
BUSINESSWIRE
ICON plc Set to Join Russell 3000® Index
26 Jun 2023 //
BUSINESSWIRE
ICON plc to Attend Upcoming Investor Conferences
31 May 2023 //
BUSINESSWIRE
ICON plc Schedules First Quarter 2023 Earnings Conference Call
29 Mar 2023 //
BUSINESSWIRE
LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology
10 Mar 2023 //
CONTRACT PHARMA
ICON plc to Present at Upcoming Investor Conferences
27 Feb 2023 //
BUSINESSWIRE
ICON Reports Fourth Quarter and Full Year 2022 Results
22 Feb 2023 //
BUSINESSWIRE
ICON recognised as leading CRO and employer by Scrip, Fierce Life Sciences
13 Dec 2022 //
BUSINESSWIRE
ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference
23 Nov 2022 //
BUSINESSWIRE
ICON plc Selected by BARDA to Execute Anthrax Vaccine Clinical Trial
10 Oct 2022 //
CONTRACTPHARMA
ICON Releases its 2021 ESG Report
06 Sep 2022 //
BUSINESSWIRE
ICON plc to Present at the 2022 Wells Fargo Healthcare Conference
31 Aug 2022 //
BUSINESSWIRE
ICON Reports Second Quarter 2022 Results
27 Jul 2022 //
BUSINESSWIRE
ICON Shareholders Vote in Favour of All Resolutions at its AGM
27 Jul 2022 //
BUSINESSWIRE
ICON plc Schedules Second Quarter 2022 Earnings Conference Call
21 Jun 2022 //
BUSINESSWIRE
ICON to present at the H.C. Wainwright Conference and the Jefferies Conference
23 May 2022 //
BUSINESSWIRE
ICON plc to present at the BofA Securities 2022 Healthcare Conference
03 May 2022 //
BUSINESSWIRE
ICON Reports First Quarter 2022 Results
27 Apr 2022 //
BUSINESSWIRE
Decentralized trials, broader services key trends for CROs
14 Jan 2022 //
FIERCEBIOTECH
ICON Announces the Expansion of its Accellacare Site Network
10 Nov 2021 //
BUSINESSWIRE
ICON acquisition creates world-leading healthcare intelligence and CRO
01 Jul 2021 //
BIOSPACE
Mylan to Acquire the Global Mkt Rights to a Once-monthly Glatiramer Acetate Mapi
10 Apr 2018 //
PR NEWSWIRE
Icon focused on smooth transition, minimal turnover, CEO on Mapi acquisition
01 Aug 2017 //
OUTSOURCING
ICON Acquires Mapi Group
27 Jul 2017 //
PHARMATECHGLOBAL
